'No Future Without New Drugs': Yuhan CSO On Open Innovation Strategy

TPD, RNA, Cell/Gene Therapies All In Sights

open innovation
Each Development Stage A 'Fight Against Success Rates' Yuhan Says • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from South Korea

More from Focus On Asia